|Bid||0.00 x 1000|
|Ask||0.00 x 1200|
|Day's Range||44.88 - 46.10|
|52 Week Range||43.39 - 80.04|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||30.54|
|Earnings Date||Feb 19, 2024 - Feb 23, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||63.58|
Subscribe to Yahoo Finance Plus to view Fair Value for GMED
Globus Medical, Inc. (NYSE:GMED) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Thank you for standing by, and welcome to the Globus Medical Third Quarter 2023 Earnings Call. [Operator Instructions]. I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead. […]
Globus Medical's (GMED) legacy business continues to drive share growth across its U.S. spine and trauma portfolios in the third quarter.
Thank you for standing by, and welcome to the Globus Medical third-quarter 2023 earnings call. Joining today's call for Globus Medical will be Dan Scavilla, president and CEO; and Keith Pfeil, chief financial officer. This review is being made available via webcast accessible through Investor Relations section of the Globus Medical website at www.globusmedical.com.